Skip to main content
. 2021 Mar 1;4(3):e210321. doi: 10.1001/jamanetworkopen.2021.0321

Table 3. Psychiatric Comorbidities Before and After Diagnosis of ADHDa.

Comorbidity Children, No. (%) P valueb
White (n = 8980) Asian (n = 365) Black (n = 682) Hispanic (n = 1034) Other/unknown (n = 340) Total (N = 11 401)
Pre-ADHD diagnosis
Speech sound disorder 1427 (15.9) 97 (26.6) 104 (15.2) 196 (19.0) 54 (15.9) 1878 (16.5) <.001
Unspecified anxiety disorder 500 (5.6) 18 (4.9) 29 (4.3) 32 (3.1) 14 (4.1) 593 (5.2) .01
Unspecified neurodevelopmental disorder 784 (8.7) 54 (14.8) 50 (7.3) 105 (10.2) 37 (10.9) 1030 (9.0) <.001
Autism spectrum disorder 527 (5.9) 62 (17.0) 43 (6.3) 68 (6.6) 22 (6.5) 722 (6.3) <.001
Adjustment disorder 1085 (12.1) 31 (8.5) 68 (10.0) 94 (9.1) 27 (7.9) 1305 (11.4) .001
Post-ADHD diagnosis
Generalized anxiety disorder 815 (9.1) 19 (5.2) 39 (5.7) 57 (5.5) 24 (7.1) 954 (8.4) <.001
Unspecified anxiety disorder 1312 (14.6) 46 (12.6) 64 (9.4) 117 (11.3) 42 (12.4) 1581 (13.9) <.001
Autism spectrum disorder 912 (10.2) 85 (23.3) 80 (11.7) 139 (13.4) 44 (12.9) 1260 (11.1) <.001

Abbreviation: ADHD, attention-deficit/hyperactivity disorder.

a

Comorbidities evaluated in the study include common pediatric internalizing and externalizing disorders.

b

P values are based on F tests.